[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

EMEA (Europe, Middle East and Africa) B-Cell Chronic Lymphocytic Leukemia Treatment Market Report 2017

January 2018 | 116 pages | ID: E86AE09F5ADEN
QYResearch

US$ 4,000.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this report, the EMEA B-Cell Chronic Lymphocytic Leukemia Treatment market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Pcs), revenue (Million USD), market share and growth rate of B-Cell Chronic Lymphocytic Leukemia Treatment for these regions, from 2012 to 2022 (forecast)
  • Europe: Germany, France, UK, Russia, Italy and Benelux;
  • Middle East: Saudi Arabia, Israel, UAE and Iran;
  • Africa: South Africa, Nigeria, Egypt and Algeria.
EMEA B-Cell Chronic Lymphocytic Leukemia Treatment market competition by top manufacturers/players, with B-Cell Chronic Lymphocytic Leukemia Treatment sales volume (K Pcs), price (USD/Pcs), revenue (Million USD) and market share for each manufacturer/player; the top players including
  • AB Science SA
  • Amgen Inc.
  • Celgene Corporation
  • Dynavax Technologies Corporation
  • Eisai
  • Elsalys Biotech SAS
  • F. Hoffmann-La Roche Ltd.
  • iDD biotech SAS
  • Immunomedics, Inc.
  • Johnson & Johnson
  • Juno Therapeutics Inc.
  • Molecular Templates Inc.
  • Noxxon Pharma AG
On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
  • AMG-319
  • ATTCK-20
  • IDD-002
  • JNJ-64052781
  • Lenalidomide
  • MAT-303
  • MT-3724
  • Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
  • Clinic
  • Hospital
  • Others
If you have any special requirements, please let us know and we will offer you the report as you want.
EMEA (Europe, Middle East and Africa) B-Cell Chronic Lymphocytic Leukemia Treatment Market Report 2017

1 B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA TREATMENT OVERVIEW

1.1 Product Overview and Scope of B-Cell Chronic Lymphocytic Leukemia Treatment
1.2 Classification of B-Cell Chronic Lymphocytic Leukemia Treatment
  1.2.1 EMEA B-Cell Chronic Lymphocytic Leukemia Treatment Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 EMEA B-Cell Chronic Lymphocytic Leukemia Treatment Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 AMG-319
  1.2.4 ATTCK-20
  1.2.5 IDD-002
  1.2.6 JNJ-64052781
  1.2.7 Lenalidomide
  1.2.8 MAT-303
  1.2.9 MT-3724
  1.2.10 Others
1.3 EMEA B-Cell Chronic Lymphocytic Leukemia Treatment Market by Application/End Users
  1.3.1 EMEA B-Cell Chronic Lymphocytic Leukemia Treatment Sales (Volume) and Market Share Comparison by Application (2012-2022
  1.3.2 Clinic
  1.3.3 Hospital
  1.3.4 Others
1.4 EMEA B-Cell Chronic Lymphocytic Leukemia Treatment Market by Region
  1.4.1 EMEA B-Cell Chronic Lymphocytic Leukemia Treatment Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 Europe Status and Prospect (2012-2022)
  1.4.3 Middle East Status and Prospect (2012-2022)
  1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of B-Cell Chronic Lymphocytic Leukemia Treatment (2012-2022)
  1.5.1 EMEA B-Cell Chronic Lymphocytic Leukemia Treatment Sales and Growth Rate (2012-2022)
  1.5.2 EMEA B-Cell Chronic Lymphocytic Leukemia Treatment Revenue and Growth Rate (2012-2022)

2 EMEA B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA TREATMENT COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA B-Cell Chronic Lymphocytic Leukemia Treatment Market Competition by Players/Manufacturers
  2.1.1 EMEA B-Cell Chronic Lymphocytic Leukemia Treatment Sales Volume and Market Share of Major Players (2012-2017)
  2.1.2 EMEA B-Cell Chronic Lymphocytic Leukemia Treatment Revenue and Share by Players (2012-2017)
  2.1.3 EMEA B-Cell Chronic Lymphocytic Leukemia Treatment Sale Price by Players (2012-2017)
2.2 EMEA B-Cell Chronic Lymphocytic Leukemia Treatment (Volume and Value) by Type/Product Category
  2.2.1 EMEA B-Cell Chronic Lymphocytic Leukemia Treatment Sales and Market Share by Type (2012-2017)
  2.2.2 EMEA B-Cell Chronic Lymphocytic Leukemia Treatment Revenue and Market Share by Type (2012-2017)
  2.2.3 EMEA B-Cell Chronic Lymphocytic Leukemia Treatment Sale Price by Type (2012-2017)
2.3 EMEA B-Cell Chronic Lymphocytic Leukemia Treatment (Volume) by Application
2.4 EMEA B-Cell Chronic Lymphocytic Leukemia Treatment (Volume and Value) by Region
  2.4.1 EMEA B-Cell Chronic Lymphocytic Leukemia Treatment Sales and Market Share by Region (2012-2017)
  2.4.2 EMEA B-Cell Chronic Lymphocytic Leukemia Treatment Revenue and Market Share by Region (2012-2017)
  2.4.3 EMEA B-Cell Chronic Lymphocytic Leukemia Treatment Sales Price by Region (2012-2017)

3 EUROPE B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA TREATMENT (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe B-Cell Chronic Lymphocytic Leukemia Treatment Sales and Value (2012-2017)
  3.1.1 Europe B-Cell Chronic Lymphocytic Leukemia Treatment Sales Volume and Growth Rate (2012-2017)
  3.1.2 Europe B-Cell Chronic Lymphocytic Leukemia Treatment Revenue and Growth Rate (2012-2017)
3.2 Europe B-Cell Chronic Lymphocytic Leukemia Treatment Sales and Market Share by Type
3.3 Europe B-Cell Chronic Lymphocytic Leukemia Treatment Sales and Market Share by Application
3.4 Europe B-Cell Chronic Lymphocytic Leukemia Treatment Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe B-Cell Chronic Lymphocytic Leukemia Treatment Sales Volume by Countries (2012-2017)
  3.4.2 Europe B-Cell Chronic Lymphocytic Leukemia Treatment Revenue by Countries (2012-2017)
  3.4.3 Germany B-Cell Chronic Lymphocytic Leukemia Treatment Sales and Growth Rate (2012-2017)
  3.4.4 France B-Cell Chronic Lymphocytic Leukemia Treatment Sales and Growth Rate (2012-2017)
  3.4.5 UK B-Cell Chronic Lymphocytic Leukemia Treatment Sales and Growth Rate (2012-2017)
  3.4.6 Russia B-Cell Chronic Lymphocytic Leukemia Treatment Sales and Growth Rate (2012-2017)
  3.4.7 Italy B-Cell Chronic Lymphocytic Leukemia Treatment Sales and Growth Rate (2012-2017)
  3.4.8 Benelux B-Cell Chronic Lymphocytic Leukemia Treatment Sales and Growth Rate (2012-2017)

4 MIDDLE EAST B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA TREATMENT (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East B-Cell Chronic Lymphocytic Leukemia Treatment Sales and Value (2012-2017)
  4.1.1 Middle East B-Cell Chronic Lymphocytic Leukemia Treatment Sales Volume and Growth Rate (2012-2017)
  4.1.2 Middle East B-Cell Chronic Lymphocytic Leukemia Treatment Revenue and Growth Rate (2012-2017)
4.2 Middle East B-Cell Chronic Lymphocytic Leukemia Treatment Sales and Market Share by Type
4.3 Middle East B-Cell Chronic Lymphocytic Leukemia Treatment Sales and Market Share by Application
4.4 Middle East B-Cell Chronic Lymphocytic Leukemia Treatment Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East B-Cell Chronic Lymphocytic Leukemia Treatment Sales Volume by Countries (2012-2017)
  4.4.2 Middle East B-Cell Chronic Lymphocytic Leukemia Treatment Revenue by Countries (2012-2017)
  4.4.3 Saudi Arabia B-Cell Chronic Lymphocytic Leukemia Treatment Sales and Growth Rate (2012-2017)
  4.4.4 Israel B-Cell Chronic Lymphocytic Leukemia Treatment Sales and Growth Rate (2012-2017)
  4.4.5 UAE B-Cell Chronic Lymphocytic Leukemia Treatment Sales and Growth Rate (2012-2017)
  4.4.6 Iran B-Cell Chronic Lymphocytic Leukemia Treatment Sales and Growth Rate (2012-2017)

5 AFRICA B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA TREATMENT (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa B-Cell Chronic Lymphocytic Leukemia Treatment Sales and Value (2012-2017)
  5.1.1 Africa B-Cell Chronic Lymphocytic Leukemia Treatment Sales Volume and Growth Rate (2012-2017)
  5.1.2 Africa B-Cell Chronic Lymphocytic Leukemia Treatment Revenue and Growth Rate (2012-2017)
5.2 Africa B-Cell Chronic Lymphocytic Leukemia Treatment Sales and Market Share by Type
5.3 Africa B-Cell Chronic Lymphocytic Leukemia Treatment Sales and Market Share by Application
5.4 Africa B-Cell Chronic Lymphocytic Leukemia Treatment Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa B-Cell Chronic Lymphocytic Leukemia Treatment Sales Volume by Countries (2012-2017)
  5.4.2 Africa B-Cell Chronic Lymphocytic Leukemia Treatment Revenue by Countries (2012-2017)
  5.4.3 South Africa B-Cell Chronic Lymphocytic Leukemia Treatment Sales and Growth Rate (2012-2017)
  5.4.4 Nigeria B-Cell Chronic Lymphocytic Leukemia Treatment Sales and Growth Rate (2012-2017)
  5.4.5 Egypt B-Cell Chronic Lymphocytic Leukemia Treatment Sales and Growth Rate (2012-2017)
  5.4.6 Algeria B-Cell Chronic Lymphocytic Leukemia Treatment Sales and Growth Rate (2012-2017)

6 EMEA B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA TREATMENT MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 AB Science SA
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 B-Cell Chronic Lymphocytic Leukemia Treatment Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 AB Science SA B-Cell Chronic Lymphocytic Leukemia Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Amgen Inc.
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 B-Cell Chronic Lymphocytic Leukemia Treatment Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Amgen Inc. B-Cell Chronic Lymphocytic Leukemia Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Celgene Corporation
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 B-Cell Chronic Lymphocytic Leukemia Treatment Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Celgene Corporation B-Cell Chronic Lymphocytic Leukemia Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Dynavax Technologies Corporation
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 B-Cell Chronic Lymphocytic Leukemia Treatment Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Dynavax Technologies Corporation B-Cell Chronic Lymphocytic Leukemia Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Eisai
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 B-Cell Chronic Lymphocytic Leukemia Treatment Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Eisai B-Cell Chronic Lymphocytic Leukemia Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Elsalys Biotech SAS
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 B-Cell Chronic Lymphocytic Leukemia Treatment Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Elsalys Biotech SAS B-Cell Chronic Lymphocytic Leukemia Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 F. Hoffmann-La Roche Ltd.
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 B-Cell Chronic Lymphocytic Leukemia Treatment Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 F. Hoffmann-La Roche Ltd. B-Cell Chronic Lymphocytic Leukemia Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 iDD biotech SAS
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 B-Cell Chronic Lymphocytic Leukemia Treatment Product Type, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 iDD biotech SAS B-Cell Chronic Lymphocytic Leukemia Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Immunomedics, Inc.
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 B-Cell Chronic Lymphocytic Leukemia Treatment Product Type, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Immunomedics, Inc. B-Cell Chronic Lymphocytic Leukemia Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Johnson & Johnson
  6.10.1 Company Basic Information, Manufacturing Base and Competitors
  6.10.2 B-Cell Chronic Lymphocytic Leukemia Treatment Product Type, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Johnson & Johnson B-Cell Chronic Lymphocytic Leukemia Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 Juno Therapeutics Inc.
6.12 Molecular Templates Inc.
6.13 Noxxon Pharma AG

7 B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA TREATMENT MANUFACTURING COST ANALYSIS

7.1 B-Cell Chronic Lymphocytic Leukemia Treatment Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of B-Cell Chronic Lymphocytic Leukemia Treatment

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 B-Cell Chronic Lymphocytic Leukemia Treatment Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of B-Cell Chronic Lymphocytic Leukemia Treatment Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA TREATMENT MARKET FORECAST (2017-2022)

11.1 EMEA B-Cell Chronic Lymphocytic Leukemia Treatment Sales, Revenue and Price Forecast (2017-2022)
  11.1.1 EMEA B-Cell Chronic Lymphocytic Leukemia Treatment Sales and Growth Rate Forecast (2017-2022)
  11.1.2 EMEA B-Cell Chronic Lymphocytic Leukemia Treatment Revenue and Growth Rate Forecast (2017-2022)
  11.1.3 EMEA B-Cell Chronic Lymphocytic Leukemia Treatment Price and Trend Forecast (2017-2022)
11.2 EMEA B-Cell Chronic Lymphocytic Leukemia Treatment Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe B-Cell Chronic Lymphocytic Leukemia Treatment Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt B-Cell Chronic Lymphocytic Leukemia Treatment Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa B-Cell Chronic Lymphocytic Leukemia Treatment Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA B-Cell Chronic Lymphocytic Leukemia Treatment Sales Forecast by Type (2017-2022)
11.7 EMEA B-Cell Chronic Lymphocytic Leukemia Treatment Sales Forecast by Application (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Product Picture of B-Cell Chronic Lymphocytic Leukemia Treatment
Figure EMEA B-Cell Chronic Lymphocytic Leukemia Treatment Sales Volume (K Pcs) by Type (2012-2022)
Figure EMEA B-Cell Chronic Lymphocytic Leukemia Treatment Sales Volume Market Share by Type (Product Category) in 2016
Figure AMG-319 Product Picture
Figure ATTCK-20 Product Picture
Figure IDD-002 Product Picture
Figure JNJ-64052781 Product Picture
Figure Lenalidomide Product Picture
Figure MAT-303 Product Picture
Figure MT-3724 Product Picture
Figure Others Product Picture
Figure EMEA B-Cell Chronic Lymphocytic Leukemia Treatment Sales Volume (K Pcs) by Application (2012-2022)
Figure EMEA Sales Market Share of B-Cell Chronic Lymphocytic Leukemia Treatment by Application in 2016
Figure Clinic Examples
Table Key Downstream Customer in Clinic
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Others Examples
Table Key Downstream Customer in Others
Figure EMEA B-Cell Chronic Lymphocytic Leukemia Treatment Market Size (Million USD) by Region (2012-2022)
Figure Europe B-Cell Chronic Lymphocytic Leukemia Treatment Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe B-Cell Chronic Lymphocytic Leukemia Treatment Revenue (Million USD) Status and Forecast by Countries
Figure Middle East B-Cell Chronic Lymphocytic Leukemia Treatment Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East B-Cell Chronic Lymphocytic Leukemia Treatment Revenue (Million USD) Status and Forecast by Countries
Figure Africa B-Cell Chronic Lymphocytic Leukemia Treatment Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa B-Cell Chronic Lymphocytic Leukemia Treatment Revenue (Million USD) Status and Forecast by Countries
Figure EMEA B-Cell Chronic Lymphocytic Leukemia Treatment Sales Volume and Growth Rate (2012-2022)
Figure EMEA B-Cell Chronic Lymphocytic Leukemia Treatment Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA B-Cell Chronic Lymphocytic Leukemia Treatment Market Major Players Product Sales Volume (K Pcs) (2012-2017)
Table EMEA B-Cell Chronic Lymphocytic Leukemia Treatment Sales Volume (K Pcs) of Major Players (2012-2017)
Table EMEA B-Cell Chronic Lymphocytic Leukemia Treatment Sales Share by Players (2012-2017)
Figure 2016 B-Cell Chronic Lymphocytic Leukemia Treatment Sales Share by Players
Figure 2017 B-Cell Chronic Lymphocytic Leukemia Treatment Sales Share by Players
Figure EMEA B-Cell Chronic Lymphocytic Leukemia Treatment Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA B-Cell Chronic Lymphocytic Leukemia Treatment Revenue (Million USD) by Players (2012-2017)
Table EMEA B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Share by Players (2012-2017)
Table 2016 EMEA B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Share by Players
Table 2017 EMEA B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Share by Players
Table EMEA B-Cell Chronic Lymphocytic Leukemia Treatment Sale Price (USD/Pcs) by Players (2012-2017)
Table EMEA B-Cell Chronic Lymphocytic Leukemia Treatment Sales (K Pcs) and Market Share by Type (2012-2017)
Table EMEA B-Cell Chronic Lymphocytic Leukemia Treatment Sales Share by Type (2012-2017)
Figure Sales Market Share of B-Cell Chronic Lymphocytic Leukemia Treatment by Type (2012-2017)
Figure EMEA B-Cell Chronic Lymphocytic Leukemia Treatment Sales Market Share by Type (2012-2017)
Table EMEA B-Cell Chronic Lymphocytic Leukemia Treatment Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Share by Type (2012-2017)
Figure Revenue Market Share of B-Cell Chronic Lymphocytic Leukemia Treatment by Type in 2016
Table EMEA B-Cell Chronic Lymphocytic Leukemia Treatment Sale Price (USD/Pcs) by Type (2012-2017)
Table EMEA B-Cell Chronic Lymphocytic Leukemia Treatment Sales (K Pcs) and Market Share by Application (2012-2017)
Table EMEA B-Cell Chronic Lymphocytic Leukemia Treatment Sales Share by Application (2012-2017)
Figure Sales Market Share of B-Cell Chronic Lymphocytic Leukemia Treatment by Application (2012-2017)
Figure EMEA B-Cell Chronic Lymphocytic Leukemia Treatment Sales Market Share by Application in 2016
Table EMEA B-Cell Chronic Lymphocytic Leukemia Treatment Sales (K Pcs) and Market Share by Region (2012-2017)
Table EMEA B-Cell Chronic Lymphocytic Leukemia Treatment Sales Share by Region (2012-2017)
Figure Sales Market Share of B-Cell Chronic Lymphocytic Leukemia Treatment by Region (2012-2017)
Figure EMEA B-Cell Chronic Lymphocytic Leukemia Treatment Sales Market Share in 2016
Table EMEA B-Cell Chronic Lymphocytic Leukemia Treatment Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Share by Region (2012-2017)
Figure Revenue Market Share of B-Cell Chronic Lymphocytic Leukemia Treatment by Region (2012-2017)
Figure EMEA B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Market Share Regions in 2016
Table EMEA B-Cell Chronic Lymphocytic Leukemia Treatment Sales Price (USD/Pcs) by Region (2012-2017)
Figure Europe B-Cell Chronic Lymphocytic Leukemia Treatment Sales (K Pcs) and Growth Rate (2012-2017)
Figure Europe B-Cell Chronic Lymphocytic Leukemia Treatment Revenue and Growth Rate (2012-2017)
Table Europe B-Cell Chronic Lymphocytic Leukemia Treatment Sales (K Pcs) by Type (2012-2017)
Table Europe B-Cell Chronic Lymphocytic Leukemia Treatment Market Share by Type (2012-2017)
Figure Europe B-Cell Chronic Lymphocytic Leukemia Treatment Market Share by Type in 2016
Table Europe B-Cell Chronic Lymphocytic Leukemia Treatment Sales (K Pcs) by Application (2012-2017)
Table Europe B-Cell Chronic Lymphocytic Leukemia Treatment Market Share by Application (2012-2017)
Figure Europe B-Cell Chronic Lymphocytic Leukemia Treatment Market Share by Application in 2016
Table Europe B-Cell Chronic Lymphocytic Leukemia Treatment Sales (K Pcs) by Countries (2012-2017)
Table Europe B-Cell Chronic Lymphocytic Leukemia Treatment Sales Market Share by Countries (2012-2017)
Figure Europe B-Cell Chronic Lymphocytic Leukemia Treatment Sales Market Share by Countries (2012-2017)
Figure Europe B-Cell Chronic Lymphocytic Leukemia Treatment Sales Market Share by Countries in 2016
Table Europe B-Cell Chronic Lymphocytic Leukemia Treatment Revenue (Million USD) by Countries (2012-2017)
Table Europe B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Market Share by Countries (2012-2017)
Figure Europe B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Market Share by Countries (2012-2017)
Figure Europe B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Market Share by Countries in 2016
Figure Germany B-Cell Chronic Lymphocytic Leukemia Treatment Sales (K Pcs) and Growth Rate (2012-2017)
Figure France B-Cell Chronic Lymphocytic Leukemia Treatment Sales (K Pcs) and Growth Rate (2012-2017)
Figure UK B-Cell Chronic Lymphocytic Leukemia Treatment Sales (K Pcs) and Growth Rate (2012-2017)
Figure Russia B-Cell Chronic Lymphocytic Leukemia Treatment Sales (K Pcs) and Growth Rate (2012-2017)
Figure Italy B-Cell Chronic Lymphocytic Leukemia Treatment Sales (K Pcs) and Growth Rate (2012-2017)
Figure Benelux B-Cell Chronic Lymphocytic Leukemia Treatment Sales (K Pcs) and Growth Rate (2012-2017)
Figure Middle East B-Cell Chronic Lymphocytic Leukemia Treatment Sales (K Pcs) and Growth Rate (2012-2017)
Figure Middle East B-Cell Chronic Lymphocytic Leukemia Treatment Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East B-Cell Chronic Lymphocytic Leukemia Treatment Sales (K Pcs) by Type (2012-2017)
Table Middle East B-Cell Chronic Lymphocytic Leukemia Treatment Market Share by Type (2012-2017)
Figure Middle East B-Cell Chronic Lymphocytic Leukemia Treatment Market Share by Type (2012-2017)
Table Middle East B-Cell Chronic Lymphocytic Leukemia Treatment Sales (K Pcs) by Applications (2012-2017)
Table Middle East B-Cell Chronic Lymphocytic Leukemia Treatment Market Share by Applications (2012-2017)
Figure Middle East B-Cell Chronic Lymphocytic Leukemia Treatment Sales Market Share by Application in 2016
Table Middle East B-Cell Chronic Lymphocytic Leukemia Treatment Sales Volume (K Pcs) by Countries (2012-2017)
Table Middle East B-Cell Chronic Lymphocytic Leukemia Treatment Sales Volume Market Share by Countries (2012-2017)
Figure Middle East B-Cell Chronic Lymphocytic Leukemia Treatment Sales Volume Market Share by Countries in 2016
Table Middle East B-Cell Chronic Lymphocytic Leukemia Treatment Revenue (Million USD) by Countries (2012-2017)
Table Middle East B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Market Share by Countries (2012-2017)
Figure Middle East B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Market Share by Countries (2012-2017)
Figure Middle East B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Market Share by Countries in 2016
Figure Saudi Arabia B-Cell Chronic Lymphocytic Leukemia Treatment Sales (K Pcs) and Growth Rate (2012-2017)
Figure Israel B-Cell Chronic Lymphocytic Leukemia Treatment Sales (K Pcs) and Growth Rate (2012-2017)
Figure UAE B-Cell Chronic Lymphocytic Leukemia Treatment Sales (K Pcs) and Growth Rate (2012-2017)
Figure Iran B-Cell Chronic Lymphocytic Leukemia Treatment Sales (K Pcs) and Growth Rate (2012-2017)
Figure Africa B-Cell Chronic Lymphocytic Leukemia Treatment Sales (K Pcs) and Growth Rate (2012-2017)
Figure Africa B-Cell Chronic Lymphocytic Leukemia Treatment Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa B-Cell Chronic Lymphocytic Leukemia Treatment Sales (K Pcs) by Type (2012-2017)
Table Africa B-Cell Chronic Lymphocytic Leukemia Treatment Sales Market Share by Type (2012-2017)
Figure Africa B-Cell Chronic Lymphocytic Leukemia Treatment Sales Market Share by Type (2012-2017)
Figure Africa B-Cell Chronic Lymphocytic Leukemia Treatment Sales Market Share by Type in 2016
Table Africa B-Cell Chronic Lymphocytic Leukemia Treatment Sales (K Pcs) by Application (2012-2017)
Table Africa B-Cell Chronic Lymphocytic Leukemia Treatment Sales Market Share by Application (2012-2017)
Figure Africa B-Cell Chronic Lymphocytic Leukemia Treatment Sales Market Share by Application (2012-2017)
Table Africa B-Cell Chronic Lymphocytic Leukemia Treatment Sales Volume (K Pcs) by Countries (2012-2017)
Table Africa B-Cell Chronic Lymphocytic Leukemia Treatment Sales Market Share by Countries (2012-2017)
Figure Africa B-Cell Chronic Lymphocytic Leukemia Treatment Sales Market Share by Countries (2012-2017)
Figure Africa B-Cell Chronic Lymphocytic Leukemia Treatment Sales Market Share by Countries in 2016
Table Africa B-Cell Chronic Lymphocytic Leukemia Treatment Revenue (Million USD) by Countries (2012-2017)
Table Africa B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Market Share by Countries (2012-2017)
Figure Africa B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Market Share by Countries (2012-2017)
Figure Africa B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Market Share by Countries in 2016
Figure South Africa B-Cell Chronic Lymphocytic Leukemia Treatment Sales (K Pcs) and Growth Rate (2012-2017)
Figure Nigeria B-Cell Chronic Lymphocytic Leukemia Treatment Sales (K Pcs) and Growth Rate (2012-2017)
Figure Egypt B-Cell Chronic Lymphocytic Leukemia Treatment Sales (K Pcs) and Growth Rate (2012-2017)
Figure Algeria B-Cell Chronic Lymphocytic Leukemia Treatment Sales (K Pcs) and Growth Rate (2012-2017)
Table AB Science SA B-Cell Chronic Lymphocytic Leukemia Treatment Basic Information List
Table AB Science SA B-Cell Chronic Lymphocytic Leukemia Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure AB Science SA B-Cell Chronic Lymphocytic Leukemia Treatment Sales (K Pcs) and Growth Rate (2012-2017)
Figure AB Science SA B-Cell Chronic Lymphocytic Leukemia Treatment Sales Market Share in EMEA (2012-2017)
Figure AB Science SA B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Market Share in EMEA (2012-2017)
Table Amgen Inc. B-Cell Chronic Lymphocytic Leukemia Treatment Basic Information List
Table Amgen Inc. B-Cell Chronic Lymphocytic Leukemia Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Amgen Inc. B-Cell Chronic Lymphocytic Leukemia Treatment Sales (K Pcs) and Growth Rate (2012-2017)
Figure Amgen Inc. B-Cell Chronic Lymphocytic Leukemia Treatment Sales Market Share in EMEA (2012-2017)
Figure Amgen Inc. B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Market Share in EMEA (2012-2017)
Table Celgene Corporation B-Cell Chronic Lymphocytic Leukemia Treatment Basic Information List
Table Celgene Corporation B-Cell Chronic Lymphocytic Leukemia Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Celgene Corporation B-Cell Chronic Lymphocytic Leukemia Treatment Sales (K Pcs) and Growth Rate (2012-2017)
Figure Celgene Corporation B-Cell Chronic Lymphocytic Leukemia Treatment Sales Market Share in EMEA (2012-2017)
Figure Celgene Corporation B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Market Share in EMEA (2012-2017)
Table Dynavax Technologies Corporation B-Cell Chronic Lymphocytic Leukemia Treatment Basic Information List
Table Dynavax Technologies Corporation B-Cell Chronic Lymphocytic Leukemia Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Dynavax Technologies Corporation B-Cell Chronic Lymphocytic Leukemia Treatment Sales (K Pcs) and Growth Rate (2012-2017)
Figure Dynavax Technologies Corporation B-Cell Chronic Lymphocytic Leukemia Treatment Sales Market Share in EMEA (2012-2017)
Figure Dynavax Technologies Corporation B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Market Share in EMEA (2012-2017)
Table Eisai B-Cell Chronic Lymphocytic Leukemia Treatment Basic Information List
Table Eisai B-Cell Chronic Lymphocytic Leukemia Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Eisai B-Cell Chronic Lymphocytic Leukemia Treatment Sales (K Pcs) and Growth Rate (2012-2017)
Figure Eisai B-Cell Chronic Lymphocytic Leukemia Treatment Sales Market Share in EMEA (2012-2017)
Figure Eisai B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Market Share in EMEA (2012-2017)
Table Elsalys Biotech SAS B-Cell Chronic Lymphocytic Leukemia Treatment Basic Information List
Table Elsalys Biotech SAS B-Cell Chronic Lymphocytic Leukemia Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Elsalys Biotech SAS B-Cell Chronic Lymphocytic Leukemia Treatment Sales (K Pcs) and Growth Rate (2012-2017)
Figure Elsalys Biotech SAS B-Cell Chronic Lymphocytic Leukemia Treatment Sales Market Share in EMEA (2012-2017)
Figure Elsalys Biotech SAS B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Market Share in EMEA (2012-2017)
Table F. Hoffmann-La Roche Ltd. B-Cell Chronic Lymphocytic Leukemia Treatment Basic Information List
Table F. Hoffmann-La Roche Ltd. B-Cell Chronic Lymphocytic Leukemia Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure F. Hoffmann-La Roche Ltd. B-Cell Chronic Lymphocytic Leukemia Treatment Sales (K Pcs) and Growth Rate (2012-2017)
Figure F. Hoffmann-La Roche Ltd. B-Cell Chronic Lymphocytic Leukemia Treatment Sales Market Share in EMEA (2012-2017)
Figure F. Hoffmann-La Roche Ltd. B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Market Share in EMEA (2012-2017)
Table iDD biotech SAS B-Cell Chronic Lymphocytic Leukemia Treatment Basic Information List
Table iDD biotech SAS B-Cell Chronic Lymphocytic Leukemia Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure iDD biotech SAS B-Cell Chronic Lymphocytic Leukemia Treatment Sales (K Pcs) and Growth Rate (2012-2017)
Figure iDD biotech SAS B-Cell Chronic Lymphocytic Leukemia Treatment Sales Market Share in EMEA (2012-2017)
Figure iDD biotech SAS B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Market Share in EMEA (2012-2017)
Table Immunomedics, Inc. B-Cell Chronic Lymphocytic Leukemia Treatment Basic Information List
Table Immunomedics, Inc. B-Cell Chronic Lymphocytic Leukemia Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Immunomedics, Inc. B-Cell Chronic Lymphocytic Leukemia Treatment Sales (K Pcs) and Growth Rate (2012-2017)
Figure Immunomedics, Inc. B-Cell Chronic Lymphocytic Leukemia Treatment Sales Market Share in EMEA (2012-2017)
Figure Immunomedics, Inc. B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Market Share in EMEA (2012-2017)
Table Johnson & Johnson B-Cell Chronic Lymphocytic Leukemia Treatment Basic Information List
Table Johnson & Johnson B-Cell Chronic Lymphocytic Leukemia Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Johnson & Johnson B-Cell Chronic Lymphocytic Leukemia Treatment Sales (K Pcs) and Growth Rate (2012-2017)
Figure Johnson & Johnson B-Cell Chronic Lymphocytic Leukemia Treatment Sales Market Share in EMEA (2012-2017)
Figure Johnson & Johnson B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Market Share in EMEA (2012-2017)
Table Juno Therapeutics Inc. B-Cell Chronic Lymphocytic Leukemia Treatment Basic Information List
Table Molecular Templates Inc. B-Cell Chronic Lymphocytic Leukemia Treatment Basic Information List
Table Noxxon Pharma AG B-Cell Chronic Lymphocytic Leukemia Treatment Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of B-Cell Chronic Lymphocytic Leukemia Treatment
Figure Manufacturing Process Analysis of B-Cell Chronic Lymphocytic Leukemia Treatment
Figure B-Cell Chronic Lymphocytic Leukemia Treatment Industrial Chain Analysis
Table Raw Materials Sources of B-Cell Chronic Lymphocytic Leukemia Treatment Major Manufacturers in 2016
Table Major Buyers of B-Cell Chronic Lymphocytic Leukemia Treatment
Table Distributors/Traders List
Figure EMEA B-Cell Chronic Lymphocytic Leukemia Treatment Sales (K Pcs) and Growth Rate Forecast (2017-2022)
Figure EMEA B-Cell Chronic Lymphocytic Leukemia Treatment Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA B-Cell Chronic Lymphocytic Leukemia Treatment Price (USD/Pcs) and Trend Forecast (2017-2022)
Table EMEA B-Cell Chronic Lymphocytic Leukemia Treatment Sales (K Pcs) Forecast by Region (2017-2022)
Figure EMEA B-Cell Chronic Lymphocytic Leukemia Treatment Sales Market Share Forecast by Region (2017-2022)
Table EMEA B-Cell Chronic Lymphocytic Leukemia Treatment Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Market Share Forecast by Region (2017-2022)
Table Europe B-Cell Chronic Lymphocytic Leukemia Treatment Sales (K Pcs) Forecast by Countries (2017-2022)
Figure Europe B-Cell Chronic Lymphocytic Leukemia Treatment Sales Market Share Forecast by Countries (2017-2022)
Table Europe B-Cell Chronic Lymphocytic Leukemia Treatment Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East B-Cell Chronic Lymphocytic Leukemia Treatment Sales (K Pcs) Forecast by Countries (2017-2022)
Figure Middle East B-Cell Chronic Lymphocytic Leukemia Treatment Sales Market Share Forecast by Countries (2017-2022)
Table Middle East B-Cell Chronic Lymphocytic Leukemia Treatment Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Market Share Forecast by Countries (2017-2022)
Table Africa B-Cell Chronic Lymphocytic Leukemia Treatment Sales (K Pcs) Forecast by Countries (2017-2022)
Figure Africa B-Cell Chronic Lymphocytic Leukemia Treatment Sales Market Share Forecast by Countries (2017-2022)
Table Africa B-Cell Chronic Lymphocytic Leukemia Treatment Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA B-Cell Chronic Lymphocytic Leukemia Treatment Sales (K Pcs) Forecast by Type (2017-2022)
Figure EMEA B-Cell Chronic Lymphocytic Leukemia Treatment Sales Market Share Forecast by Type (2017-2022)
Table EMEA B-Cell Chronic Lymphocytic Leukemia Treatment Sales (K Pcs) Forecast by Application (2017-2022)
Figure EMEA B-Cell Chronic Lymphocytic Leukemia Treatment Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

More Publications

Need Help?

Ask a Question

Market Reports

All Categories